Ropivacaine Readyfusor 0.2% TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: ropivacaine
Pack: Ropivacaine Readyfusor 0.2% 500 mg/250 mL injection, 250 mL bottle
Brand name
(ARTG)
: ROPIVACAINE READYFUSOR ropivacaine hydrochloride 0.2% solution for injection, bottle in dispenser deviceDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Ropivacaine ReadyFusOR (0.2% ropivacaine solution for injection) is indicated for: - Continuous peripheral nerve block infiltration for postoperative pain management in adults - Continuous wound infiltration for postoperative pain management in adults,(Data for peripheral nerve block administered as a continuous peripheral infusion and for continuous wound infusion support the use for up to 48 hours only).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Infiltration
- 250 mL drug reservoir compressible bottle in a dispenser with an indicator window in the dispenser to show drug level
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Do not Freeze
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- One unit pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ropivacaine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
